Breakthrough: Drug heralded as 'game changer' in the growing national obesity crisis. #predictions #weightloss #groundbreaking www.yahoo.com/gma/newly-approved-drug-heralded-game-192619502.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
A potential 'game changer' drug for weight loss and obesity was just approved by the FDA www.businessinsider.com/weight-loss-obesity-drug-fda-approved-wegovy-2021-6
FDA Approves 'Game Changer' Weight Loss Drug, Likely First in a New Era of Obesity Treatment gizmodo.com/fda-approves-wegovy-likely-first-in-a-new-era-of-obesi-1847036266?utm_medium=sharefromsite&utm_source=gizmodo_twitter via @gizmodo
Is Semaglutide available for weight loss?
The FDA approved once-weekly semaglutide injection for chronic weight management in adults with obesity or with overweight and at least one weight-related condition, according to an agency press release. HealioFDA approves once-weekly semaglutide for weight loss
When can I get Wegovy?
Wegovy is indicated for adults who are obese (body mass index ≥30) or overweight (body mass index ≥27), and who also have certain weight-related medical conditions, such as type 2 diabetes, hypertension, and high cholesterol. ForbesNewly Approved Obesity Drug Wegovy Holds Promise, But Faces Reimbursement Challenges
What is the name of the new weight loss drug approved by the FDA?
June 7, 2021 — The FDA has approved a drug to help in weight loss among overweight or obese adults. The drug, semaglutide, "induces weight loss by reducing hunger, increasing feelings of fullness, and thereby helping people eat less and reduce their calorie intake," according to a company statement. WebMDFDA Approves 'Game Changer' Drug for Weight Loss In clinical trials, participants lost up to 15
How does Wegovy work?
Manufactured by Danish pharmaceutical company Novo Nordisk, Wegovy suppresses appetites through the hormone semaglutide. Semaglutide is a glucagon-like peptide-1 also used in diabetes treatments, reported Science Alert. Wegovy involves a once-a-week injection, said Fox News. Deseret NewsFDA approves Wegovy weight loss drug. What does it do?
A healthy diet and exercise tend to be healthy starts for weight loss, but sometimes you need that extra boost to get you on the right track toward a healthy weight. A medication that's just been approved by the FDA is making headlines for that reason, after research demonstrated that it's safer and more effective than many other weight-loss drugs.
The Associated Press reported Friday that Wegovy, a new weight loss drug, will likely soon hit the market for consumer use. That's after recent company-funded research demonstrated that the injectable drug has been shown to help manage weight loss safely, gaining FDA approval. Wegovy is a higher dose of the diabetes medication semaglutide, which has been shown to increase sugar metabolism.
The AP reports that study participants who took Wegovy lost an average 15% of body weight, or 34 pounds on average. This is a leg up on competitors, said Dr. Harold Bays, the Obesity Medicine Association's chief science officer, who helped conduct Wegovy studies: "With existing drugs, you're going to get maybe 5% to 10% weight reduction, sometimes not even that," Bays said. Further, participants saw their weight-loss patterns sustained for an average of 14 months before the rate of weight loss plateaued.
One other plus for Wegovy is that it's said to be safer than many drugs that have been developed to target obesity. The AP reports that the most common side effects from Wegovy were gastrointestinal problems, such nausea, diarrhea, and vomiting. "Those usually subsided," the AP reports, "but led about 5% of study participants to stop taking it." It's also said that in some cases, a thryoid tumor, depression, and pancreatic inflammation developed. Wegovy "shouldn't be taken by people with a personal or family history of certain thyroid and endocrine tumors," according to the AP.
Sign up for our newsletter for nutrition news and healthy inspiration, and keep reading:
Like us on Facebook to see similar stories
Please give an overall site rating:
Read full article at Yahoo Entertainment
07 June, 2021 - 08:02pm